Human immunodeficiency virus therapeutics and pharmacogenomics
2011

HIV Treatment and Genetic Factors

Sample size: 136000 publication 10 minutes Evidence: moderate

Author Information

Author(s): Shankarkumar U., Shankarkumar A., Ghosh K.

Primary Institution: National Institute of Immunohaematology

Hypothesis

How do genetic variations affect the response to HIV treatment?

Conclusion

Pharmacogenomics can help personalize HIV treatment by understanding genetic variations that influence drug response.

Supporting Evidence

  • Pharmacogenomics studies how genetic variations affect drug response.
  • More than 25 FDA approved antiretroviral drugs are available for HIV treatment.
  • Genetic variations can lead to different responses to HIV medications.
  • Certain genetic markers can predict adverse reactions to specific HIV drugs.

Takeaway

Scientists are studying how our genes affect how well HIV medicines work, which could help doctors give better treatments.

Methodology

The study reviews the role of pharmacogenomics in HIV treatment and discusses various genetic factors affecting drug response.

Limitations

The study relies on existing data and may not cover all genetic variations affecting treatment.

Participant Demographics

The study includes a diverse population of 136,000 individuals enrolled in clinical trials.

Digital Object Identifier (DOI)

10.4103/0971-6866.80354

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication